The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
IN VITRO DIAGNOSTICS Financings Biocept Inc. Biocept Inc. (blood-based molecular diagnostics for solid tumors) netted $8.7mm through the sale of 4.3mm common shares at $2.15 (a slight discount) to
Exhibit 1 Top Alliances In January 2012 *Potential Deal Value is the sum of up-front fees plus pre-commercialization money Elsevier’s Strategic Transactions Exhibit 2 Top Mergers & Acquisitions In Jan